In Vivo Two-photon Imaging of Megakaryocytes and Proplatelets in the Mouse Skull Bone Marrow
July 28th, 2021
4.1K views
We describe here the method for imaging megakaryocytes and proplatelets in the marrow of the skull bone of living mice using two-photon microscopy.
Overview
This article presents a detailed protocol for real-time imaging of fluorescently labeled megakaryocytes and sinusoid vessels in the mouse skull bone marrow using two-photon microscopy. The method enables visualization and quantification of proplatelet formation and platelet dynamics in vivo, providing insights into the mechanisms of platelet production under near-physiological conditions.
Key Study Components
Area of Science
- Hematology
- Cell Biology
- Imaging Techniques
Background
- Platelets are produced by megakaryocytes in the bone marrow.
- Proplatelet formation involves the extension of elongated protrusions into sinusoid vessels.
- In vivo imaging of these processes provides a more accurate understanding compared to in vitro studies.
- Blood flow dynamics play a crucial role in proplatelet elongation in vivo.
Purpose of Study
- To develop and demonstrate a protocol for real-time imaging of megakaryocytes and proplatelet formation in the mouse skull bone marrow.
- To quantify morphological and dynamic parameters of proplatelet formation.
- To enable pharmacological and genetic studies of platelet production in vivo.
Methods Used
- Minor surgical preparation to expose the mouse skull bone marrow while minimizing inflammation.
- Immobilization of the mouse head using a glued ring and dental paste.
- Intravenous catheterization for administration of fluorescent tracers and drugs.
- Two-photon microscopy for real-time imaging of megakaryocytes, proplatelets, and sinusoid vessels.
- Quantitative analysis of proplatelet morphology, elongation velocity, and platelet flow dynamics.
Main Results
- Successful real-time visualization of megakaryocytes extending proplatelets into sinusoid vessels.
- Observation of diverse proplatelet morphologies and dynamic behaviors, including elongation, stasis, and retraction.
- Measurement of proplatelet width (mean 5.2 μm), maximal length (mean ~185 μm), and elongation velocity (mean ~10 μm/min).
- Documentation of complex blood flow patterns in sinusoid vessels, affecting proplatelet behavior.
- Demonstration that hydrodynamic forces are critical for proplatelet elongation in vivo.
Conclusions
- This protocol enables detailed in vivo study of platelet formation mechanisms.
- It allows for the assessment of genetic and pharmacological interventions on megakaryocyte and platelet dynamics.
- The method complements in vitro studies and reveals the importance of blood flow in proplatelet elongation.
Frequently Asked Questions
What is the main advantage of this imaging protocol?
The protocol allows real-time, in vivo visualization of megakaryocyte and proplatelet dynamics in the mouse skull bone marrow with minimal inflammatory response due to minor surgical intervention.
How are megakaryocytes and vessels visualized?
Fluorescent tracers are administered intravenously to label the vasculature, and two-photon microscopy is used to image fluorescently labeled megakaryocytes and sinusoid vessels.
What parameters can be quantified using this method?
Researchers can measure proplatelet width, length, elongation velocity, morphological features, and platelet flow dynamics such as velocity and direction.
How does blood flow affect proplatelet formation?
Blood flow provides hydrodynamic forces that are essential for proplatelet elongation in vivo, as demonstrated by changes in proplatelet behavior when flow is altered or stopped.
Can this protocol be used for pharmacological studies?
Yes, the intravenous catheter allows for real-time administration of drugs to study their effects on proplatelet formation and platelet dynamics.
What are the differences between in vivo and in vitro proplatelet formation?
In vitro, microtubules are required for proplatelet elongation, while in vivo, they serve as a scaffold and elongation is mainly driven by blood flow forces.
What types of proplatelet morphologies were observed?
The study observed proplatelets with irregular margins, elongated forms, and thick, short morphologies, reflecting the diversity of proplatelet structures in vivo.
Executive Industry Relevance
Real-time in vivo two-photon imaging of megakaryocytes and proplatelets in mouse skull bone marrow enables direct observation of platelet biogenesis under near-physiological conditions. This capability advances mechanistic de-risking and target validation for hematology drug discovery, particularly for interventions affecting platelet production. The method supports translational continuity by bridging in vitro findings with in vivo functional outcomes relevant to preclinical models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct visualization of megakaryocyte behavior and proplatelet formation in a native bone marrow environment.
- Supports functional validation of genetic targets implicated in platelet production using genetically modified mice.
- Facilitates mechanistic de-risking by quantifying the impact of candidate genes or pathways on proplatelet dynamics.
- Provides predictive confidence for target selection by correlating morphological and kinetic parameters with genetic or pharmacological perturbations.
Screening & Assay Development
- Establishes a validated in vivo imaging platform for quantitative assessment of platelet biogenesis.
- Enables reproducible measurement of proplatelet morphology, elongation velocity, and platelet flow dynamics.
- Supports assay standardization for evaluating drug effects on platelet formation in real time.
- Prepares a robust system for downstream compound screening targeting thrombopoiesis.
Translational & Preclinical Research
- Aligns in vivo imaging outputs with disease-relevant platelet production phenotypes.
- Facilitates translational biomarker development by linking imaging-derived metrics to functional platelet outcomes.
- Enables risk-adjusted advancement of candidates by providing preclinical evidence of efficacy or mechanism.
- Supports continuity from discovery through preclinical validation in hematology portfolios.
Pipeline & Workflow Integration
This imaging method integrates into the discovery-to-preclinical continuum, enabling hypothesis testing, target validation, and pharmacological evaluation in a single workflow.
- Discovery Biology: Quantifies the effects of genetic or pharmacological interventions on megakaryocyte and proplatelet dynamics in vivo.
- Screening: Provides standardized, quantitative outputs for compound evaluation in thrombopoiesis research.
- Analytics: Delivers high-content measurements of proplatelet morphology, elongation kinetics, and platelet flow for comparative analysis.
- Translational Research: Bridges in vitro and in vivo findings, supporting biomarker alignment and disease relevance.
- Enterprise Reuse: Offers a reusable imaging platform adaptable to diverse genetic models and drug testing scenarios.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in platelet biogenesis research.
- Operational Value: Delivers standardized, reproducible, and scalable imaging outputs for cross-study comparison.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing robust in vivo evidence early in the pipeline.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of hematology candidates based on functional in vivo data.
Implementation Considerations
- Requires expertise in two-photon microscopy and small animal surgical techniques.
- Demands access to advanced imaging instrumentation and analytical software for quantitative analysis.
- Necessitates cross-team standardization of imaging protocols and data interpretation.
- Adaptable to various genetically modified mouse models and pharmacological interventions.
- Imaging duration and animal handling must be optimized to minimize physiological artifacts and ensure data quality.
Biopharma FAQs
Why does null hypothesis testing matter for proplatelet elongation analysis?
Null hypothesis testing enables objective evaluation of whether observed changes in proplatelet elongation or morphology are statistically significant following genetic or pharmacological interventions, supporting robust target validation decisions.
How does independent variable isolation fit the platelet velocity measurement workflow?
Isolating variables such as blood flow or drug administration allows precise attribution of changes in platelet velocity and proplatelet behavior to specific experimental manipulations, strengthening mechanistic insights in discovery pipelines.
What do quantitative dependent variable measurements enable in megakaryocyte imaging?
Quantitative measurements of proplatelet width, length, and elongation velocity provide actionable data for comparing genetic models or drug effects, enabling data-driven prioritization and cross-study reproducibility.
Why are replication requirements critical for cross-functional imaging studies?
Replication ensures that observed effects on proplatelet formation and platelet dynamics are consistent and reproducible across experiments, facilitating reliable data sharing and collaboration between discovery and translational teams.
What statistical analysis capabilities are required before implementing proplatelet quantification?
Robust statistical tools are needed to analyze morphological and kinetic parameters, assess significance, and control for biological variability, ensuring that imaging-derived metrics inform confident R&D decisions.
